BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10502035)

  • 21. Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy.
    Hino N; Kobayashi M; Shibata N; Yamamoto T; Saito K; Osawa M
    Brain Dev; 2001 Mar; 23(2):97-107. PubMed ID: 11248458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane.
    Matsubara S; Mizuno Y; Kitaguchi T; Isozaki E; Miyamoto K; Hirai S
    Neuromuscul Disord; 1999 Oct; 9(6-7):388-98. PubMed ID: 10545042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy.
    Yamamoto T; Toyoda C; Kobayashi M; Kondo E; Saito K; Osawa M
    Brain Dev; 1997 Jan; 19(1):35-42. PubMed ID: 9071488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type).
    Takada K; Nakamura H; Tanaka J
    J Neuropathol Exp Neurol; 1984 Jul; 43(4):395-407. PubMed ID: 6737009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal expression of the fukutin gene.
    Sasaki J; Ishikawa K; Kobayashi K; Kondo-Iida E; Fukayama M; Mizusawa H; Takashima S; Sakakihara Y; Nakamura Y; Toda T
    Hum Mol Genet; 2000 Dec; 9(20):3083-90. PubMed ID: 11115853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological study of the brainstem in Fukuyama type congenital muscular dystrophy.
    Itoh M; Houdou S; Kawahara H; Ohama E
    Pediatr Neurol; 1996 Nov; 15(4):327-31. PubMed ID: 8972533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital muscular dystrophy of the Fukuyama type (FCMD) with severe myocardial fibrosis. A case report with postmortem angiography.
    Miura K; Shirasawa H
    Acta Pathol Jpn; 1987 Nov; 37(11):1823-35. PubMed ID: 3439458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital muscular dystrophy with characteristic radiological findings similar to those with Fukuyama congenital muscular dystrophy.
    Garg A; Gulati S; Gupta V; Kalra V
    Neurol India; 2004 Dec; 52(4):496-8. PubMed ID: 15626844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.
    Arikawa E; Ishihara T; Nonaka I; Sugita H; Arahata K
    J Neurol Sci; 1991 Sep; 105(1):79-87. PubMed ID: 1795174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fukuyama type congenital muscular dystrophy--two Dutch siblings.
    Peters AC; Bots GT; Roos RA; van Gelderen HH
    Brain Dev; 1984; 6(4):406-16. PubMed ID: 6496876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy.
    Kato R; Kawamura J; Sugawara H; Niikawa N; Matsumoto N
    Am J Med Genet A; 2004 May; 127A(1):54-57. PubMed ID: 15103718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation.
    Yamamoto T; Shibata N; Kanazawa M; Kobayashi M; Komori T; Ikeya K; Kondo E; Saito K; Osawa M
    Acta Neuropathol; 1997 Aug; 94(2):173-9. PubMed ID: 9255393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
    Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T
    Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional MR imaging of brain surface anomalies in Fukuyama-type congenital muscular dystrophy.
    Toda T; Watanabe T; Matsumura K; Sunada Y; Yamada H; Nakano I; Mannen T; Kanazawa I; Shimizu T
    Muscle Nerve; 1995 May; 18(5):508-17. PubMed ID: 7739638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
    Hu H; Yang Y; Eade A; Xiong Y; Qi Y
    J Comp Neurol; 2007 Mar; 501(1):168-83. PubMed ID: 17206611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
    Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
    Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fukuyama congenital muscular dystrophy: a neuroradiologic review.
    Aida N
    J Magn Reson Imaging; 1998; 8(2):317-26. PubMed ID: 9562058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebro-ocular dysplasia-muscular dystrophy (COD-MD) syndrome.
    Towfighi J; Sassani JW; Suzuki K; Ladda RL
    Acta Neuropathol; 1984; 65(2):110-23. PubMed ID: 6441438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cerebellar and thalamic degeneration in Fukuyama-type congenital muscular dystrophy.
    Kumada S; Tsuchiya K; Takahashi M; Takesue M; Shiotsu H; Nomura Y; Segawa M; Ikeda K; Hayashi M
    Acta Neuropathol; 2000 Feb; 99(2):209-13. PubMed ID: 10672329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.